Strongbridge is committed to bridging treatment gaps as rapidly as possible. We are building rare disease franchises that aim to utilize accelerated regulatory pathways when possible.
The Strongbridge leadership team exemplifies the company’s approach—rare focus, rare commitment, and rare passion.
We are called Strongbridge for a reason. We’re building a strong clinical and financial foundation to connect patients with new treatments for rare diseases.